We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Economic Impact of Progression of Age-related Macular Degeneration.
- Authors
Schmier, Jordana K.; Levine, Jessica A.
- Abstract
While a good deal is known about the economic impact of blindness and low vision worldwide, there is less known about of age-related macular degeneration (AMD), particularly the difference in costs as the condition progresses. This review summarizes what is known about the economic burden of AMD by disease stage. Of particular interest are the types of costs relevant and included for each stage and the methods with which stage is assigned. Across study methods and countries, the cost of drusen and dry AMD appear similar, with the costs of wet AMD many times higher. The distribution of costs varies across disease stage, with greater cost for diagnostic procedures with earlier AMD and more on caregiving and institutional care with wet AMD. Little is known about the incremental impact of bilateral AMD, and the primary reason for that limitation seems to be the wide use of claims databases rather than clinical records or enrolling only patients with bilateral disease.
- Subjects
AGE factors in retinal degeneration; DISEASE progression; BLINDNESS; INSTITUTIONAL care; VISION disorders
- Publication
U.S. Ophthalmic Review, 2013, Vol 6, Issue 1, p52
- ISSN
1756-1795
- Publication type
Article
- DOI
10.17925/USOR.2013.06.01.52